Preclinical Alzheimer's disease

被引：1
作者：
Gil-Gregorio, P. [1 ]
Yubero-Pancorbo, R. [1 ]
机构：
[1] Hosp Clin San Carlos, Dept Geriatr, Memory Unit, Madrid, Spain
来源：
REVIEWS IN CLINICAL GERONTOLOGY | 2014年 / 24卷 / 02期
关键词：
Alzheimer's disease; preclinical stages; amyloidosis; neurodegeneration; cognition;
D O I：
10.1017/S095925981400001X
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Recently, diagnostic criteria for preclinical Alzheimer's disease have been proposed. These describe and define three stages of disease. Stage I is focused on asymptomatic cerebral amyloidosis. Stage II includes evidence of synaptic dysfunction and/or early degeneration. Finally, stage III of the disease is characterized by the beginning of cognitive decline.
引用
收藏
页码：117 / 121
页数：5
相关论文
共 17 条
[1]   Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly [J].
Becker, J. Alex ;
Hedden, Trey ;
Carmasin, Jeremy ;
Maye, Jacqueline ;
Rentz, Dorene M. ;
Putcha, Deepti ;
Fischl, Bruce ;
Greve, Douglas N. ;
Marshall, Gad A. ;
Salloway, Stephen ;
Marks, Donald ;
Buckner, Randy L. ;
Sperling, Reisa A. ;
Johnson, Keith A. .
ANNALS OF NEUROLOGY, 2011, 69 (06) :1032-1042
[2]   MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults [J].
Dickerson, Bradford C. ;
Wolk, David A. .
NEUROLOGY, 2012, 78 (02) :84-90
[3]   Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria [J].
Dubois, Bruno ;
Feldman, Howard H. ;
Jacova, Claudia ;
Dekosky, Steven T. ;
Barberger-Gateau, Pascale ;
Cummings, Jeffrey ;
Delocourte, Andre ;
Galasko, Douglas ;
Gauthier, Serge ;
Jicha, Gregory ;
Meguro, Kenichi ;
O'Brien, John ;
Pasquier, Florence ;
Robert, Philippe ;
Rossor, Martin ;
Solloway, Steven ;
Stern, Yaakov ;
Visser, Pieter J. ;
Scheltens, Philip .
LANCET NEUROLOGY, 2007, 6 (08) :734-746
[4]   Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease [J].
Ewers, Michael ;
Insel, Philip S. ;
Stern, Yaakov ;
Weiner, Michael W. .
NEUROLOGY, 2013, 80 (13) :1194-1201
[5]   MEG Delta Mapping Along the Healthy Aging-Alzheimer's Disease Continuum: Diagnostic Implications [J].
Fernandez, Alberto ;
Turrero, Agustin ;
Zuluaga, Pilar ;
Gil-Gregorio, Pedro ;
del Pozo, Francisco ;
Maestu, Fernando ;
Moratti, Stephan .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (03) :495-507
[6]   Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease -: A comparative cerebrospinal fluid study [J].
Hampel, H ;
Buerger, K ;
Zinkowski, R ;
Teipel, SJ ;
Goernitz, A ;
Andreasen, N ;
Sjoegren, M ;
DeBernardis, J ;
Kerkman, D ;
Ishiguro, K ;
Ohno, H ;
Vanmechelen, E ;
Vanderstichele, H ;
McCulloch, C ;
Möller, HJ ;
Davies, P ;
Blennow, K .
ARCHIVES OF GENERAL PSYCHIATRY, 2004, 61 (01) :95-102
[7]   Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease [J].
Ikonomovic, Milos D. ;
Klunk, William E. ;
Abrahamson, Eric E. ;
Mathis, Chester A. ;
Price, Julie C. ;
Tsopelas, Nicholas D. ;
Lopresti, Brian J. ;
Ziolko, Scott ;
Bi, Wenzhu ;
Paljug, William R. ;
Debnath, Manik L. ;
Hope, Caroline E. ;
Isanski, Barbara A. ;
Hamilton, Ronald L. ;
DeKosky, Steven T. .
BRAIN, 2008, 131 :1630-1645
[8]   Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade [J].
Jack, Clifford R., Jr. ;
Knopman, David S. ;
Jagust, William J. ;
Shaw, Leslie M. ;
Aisen, Paul S. ;
Weiner, Michael W. ;
Petersen, Ronald C. ;
Trojanowski, John Q. .
LANCET NEUROLOGY, 2010, 9 (01) :119-128
[9]   Relationships between biomarkers in aging and dementia [J].
Jagust, W. J. ;
Landau, S. M. ;
Shaw, L. M. ;
Trojanowski, J. Q. ;
Koeppe, R. A. ;
Reiman, E. M. ;
Foster, N. L. ;
Petersen, R. C. ;
Weiner, M. W. ;
Price, J. C. ;
Mathis, C. A. .
NEUROLOGY, 2009, 73 (15) :1193-1199
[10]   Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review [J].
Knopman, David S. ;
Caselli, Richard J. .
NEURODEGENERATIVE DISEASE MANAGEMENT, 2012, 2 (02) :183-195
12